menu
    • menu
    [{"orgOrder":0,"company":"Atabay","sponsor":"Novagenix Bioanalytical R&D Center | Farmagen Ar-Ge","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"TURKEY","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Favipiravir","moa":"RNA-directed RNA polymerase","graph1":"Undisclosed","graph2":"Phase I","graph3":"Atabay","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Atabay \/ Novagenix Bioanalytical R&D Center | Farmagen Ar-Ge","highestDevelopmentStatusID":"6","companyTruncated":"Atabay \/ Novagenix Bioanalytical R&D Center | Farmagen Ar-Ge"},{"orgOrder":0,"company":"Atabay","sponsor":"Novagenix Bioanalytical R&D Center | Farmagen Ar-Ge","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"TURKEY","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Atafenovir","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I","graph3":"Atabay","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Atabay \/ Novagenix Bioanalytical R&D Center | Farmagen Ar-Ge","highestDevelopmentStatusID":"6","companyTruncated":"Atabay \/ Novagenix Bioanalytical R&D Center | Farmagen Ar-Ge"},{"orgOrder":0,"company":"Atabay","sponsor":"Atabay","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Neoven 225","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Phase IV","graph3":"Atabay","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Atabay \/ Atabay","highestDevelopmentStatusID":"11","companyTruncated":"Atabay \/ Atabay"}]

    Find Clinical Drug Pipeline Developments & Deals by Atabay

    Menu

    Atabay

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Atabay

                            Turkey arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Atabay

                            Turkey arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Neoven 225

                            Therapeutic Area : Gastroenterology

                            Study Phase : Phase IV

                            Recipient : Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy and Safety Evaluation of Ruscus Aculeatus L in Patients with Hemorrhoids

                            Details : Neoven 225 is a Dietary Supplement drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Hemorrhoids.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            August 19, 2025

                            Lead Product(s) : Neoven 225

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Phase IV

                            Recipient : Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Atabay

                            Turkey arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Atabay

                            Turkey arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Atafenovir

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : Novagenix Bioanalytical R&D Center | Farmagen Ar-Ge

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Bioequivalence Study of Umifenovir 200 mg Capsul (ATABAY, Turkey) Under Fasting Conditions

                            Details : Atafenovir is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            July 20, 2020

                            Lead Product(s) : Atafenovir

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : Novagenix Bioanalytical R&D Center | Farmagen Ar-Ge

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Atabay

                            Turkey arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Atabay

                            Turkey arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Favipiravir

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : Novagenix Bioanalytical R&D Center | Farmagen Ar-Ge

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting Conditions

                            Details : Favipiravir is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            May 28, 2020

                            Lead Product(s) : Favipiravir

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : Novagenix Bioanalytical R&D Center | Farmagen Ar-Ge

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth